--- title: "Photronics | 10-K: FY2025 Revenue Beats Estimate at USD 849.29 M" type: "News" locale: "en" url: "https://longbridge.com/en/news/270054593.md" datetime: "2025-12-17T19:26:44.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/270054593.md) - [en](https://longbridge.com/en/news/270054593.md) - [zh-HK](https://longbridge.com/zh-HK/news/270054593.md) --- > Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/270054593.md) | [繁體中文](https://longbridge.com/zh-HK/news/270054593.md) # Photronics | 10-K: FY2025 Revenue Beats Estimate at USD 849.29 M Revenue: As of FY2025, the actual value is USD 849.29 M, beating the estimate of USD 838.05 M. EPS: As of FY2025, the actual value is USD 2.28, beating the estimate of USD 1.68. EBIT: As of FY2025, the actual value is USD 208.22 M. ### Segment Revenue - **IC Revenue**: $615.1 million in FY25, a decrease of 3.6% from FY24 ($638.2 million) and a decrease of 5.6% from FY23 ($651.3 million). - **FPD Revenue**: $234.2 million in FY25, an increase of 2.4% from FY24 ($228.8 million) and a decrease of 2.7% from FY23 ($240.8 million). ### Operational Metrics - **Gross Profit**: $299.8 million in FY25, a decrease of 5.1% from FY24 ($315.9 million) and a decrease of 10.8% from FY23 ($336.2 million). - **Gross Margin**: 35.3% in FY25, down from 36.4% in FY24 and 37.7% in FY23. - **Operating Income**: $208.2 million in FY25, a decrease of 6.0% from FY24 ($221.5 million) and a decrease of 17.7% from FY23 ($253.1 million). - **Operating Margin**: 24.5% in FY25, down from 25.6% in FY24 and 28.4% in FY23. - **Net Income**: $190.2 million in FY25, an increase of 3.5% from FY24 ($183.8 million) and a decrease of 4.7% from FY23 ($199.6 million). - **Net Income Attributable to Photronics, Inc. Shareholders**: $136.4 million in FY25, an increase of 4.4% from FY24 ($130.7 million) and an increase of 8.7% from FY23 ($125.5 million). ### Cash Flow - **Net Cash Provided by Operating Activities**: $247.8 million in FY25, a decrease of 5.2% from FY24 ($261.4 million) and a decrease of 18.0% from FY23 ($302.2 million). - **Net Cash Used in Investing Activities**: $238.9 million in FY25, an increase of 52.7% from FY24 ($156.5 million) and an increase of 135.3% from FY23 ($101.5 million). - **Net Cash Used in Financing Activities**: $115.3 million in FY25, an increase of 1393.5% from FY24 ($7.7 million) and an increase of 523.2% from FY23 ($18.5 million). ### Unique Metrics - **Research and Development Expenses**: $15.8 million in FY25, a decrease of 4.8% from FY24 ($16.6 million) and an increase of 15.3% from FY23 ($13.7 million). - **Capital Expenditures**: $188.1 million in FY25, an increase of 43.7% from FY24 ($130.9 million) and an increase of 43.3% from FY23 ($131.3 million). ### Outlook / Guidance - **Capital Expenditures for FY26**: Expected to be approximately $330 million, targeted towards high-end and mainstream “point” tools to increase operating capacity and efficiency. - **Revenue Growth**: The company expects advanced-generation designs to continue to move to production throughout fiscal 2026, positioning them to service an increasing volume of this business. - **Investment in Technology**: Continued investments in manufacturing processes and technology in regions where customers are located to support technological and production requirements. ### Related Stocks - [Photronics, Inc. (PLAB.US)](https://longbridge.com/en/quote/PLAB.US.md) ## Related News & Research - [Wedge Capital Management L L P NC Cuts Stock Holdings in Photronics, Inc. $PLAB](https://longbridge.com/en/news/281011330.md) - [JPMorgan Chase & Co. Reduces Position in Photronics, Inc. $PLAB](https://longbridge.com/en/news/281493282.md) - [Reviva Reports Full Year 2025 Financial Results and Recent Business Highlights | RVPH Stock News](https://longbridge.com/en/news/280996019.md) - [Wealth First Promoters Confirm 74% Stake With No Encumbrance in FY26](https://longbridge.com/en/news/281530653.md) - [Earnings Flash (NKE) Nike Posts Fiscal Q3 EPS $0.35, vs. FactSet Est of $0.29](https://longbridge.com/en/news/281238335.md)